abnormal facial morphology_Ids<tm1Eto>/Ids<tm1Eto>

http://metadb.riken.jp/0003743IC57BL6Idstm1EtoIdstm1EtoIdstm1Eto

abnormal facial morphology_Ids<tm1Eto>/Ids<tm1Eto>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• iduronate 2-sulfatase
  http://metadb.riken.jp/db/mgi_rdf/MGI:96417

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Ids<tm1Eto>/Ids<tm1Eto>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Ids<tm1Eto>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal facial morphology
  http://purl.obolibrary.org/obo/MP_0003743

文献

http://purl.org/net/cito/citesAsAuthority

• Takashi. Higuchi, et.al., Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II., Molecular genetics and metabolism, 2012, 107
  http://rdf.ncbi.nlm.nih.gov/pubmed/22704483